Literature DB >> 26996285

Obesity and trauma mortality: Sizing up the risks in motor vehicle crashes.

Bellal Joseph1, Steven Hadeed2, Ansab A Haider2, Michael Ditillo3, Aly Joseph2, Viraj Pandit2, Narong Kulvatunyou2, Andrew Tang2, Rifat Latifi2, Peter Rhee2.   

Abstract

BACKGROUND: Protective effects of safety devices in obese motorists in motor vehicle collisions (MVC) remain unclear. Aim of our study is to assess the association between morbid obesity and mortality in MVC, and to determine the efficacy of protective devices. We hypothesised that patients with morbid obesity will be at greater risk of death after MVC.
METHODS: A retrospective analysis of MVC patients (age ≥16 y.o.) was performed using the National Trauma Data Bank from 2007 to 2010. Patients with recorded comorbidity of morbid obesity (BMI≥40) were identified. Patients dead on arrival, with isolated traumatic brain injury, or incomplete data were excluded. The primary outcome was in-hospital mortality. Multivariate logistic regression was performed.
RESULTS: Our sample of 214,306 MVC occupants included 10,260 (4.8%) morbidly obese patients. Mortality risk was greatest among occupants with morbid obesity (ORcrude 1.74 [1.54-1.98]). After adjusting for patient demographics, safety device and physiological severity, odds of death was 1.52 [1.33-1.74] times greater in motorists with morbid obesity. Motorists with morbid obesity were at greater risk of death if no restraint (OR 1.84 [1.47-2.31]), seatbelt only (OR 1.48 [1.17-1.86]), or both seatbelt and airbag were present (OR 1.49 [1.13-1.97]). No significant differences in the odds of death exist between drivers with morbid obesity and non-morbidly obese drivers with only airbag deployment (OR 0.99 [0.65-1.51]).
CONCLUSIONS: Motorists with morbid obesity are at greater risk of MVC. Regardless of safety device use, occupants with morbid obesity remained at greater risk of death. Further research examining the effectiveness of vehicle restraints in drivers with morbid obesity is warranted.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Mortality; Motor vehicle collision; Obesity

Mesh:

Year:  2016        PMID: 26996285     DOI: 10.1016/j.orcp.2016.03.003

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  5 in total

1.  Obesity is associated with postinjury hypercoagulability.

Authors:  Jason M Samuels; Ernest E Moore; Julia R Coleman; Joshua J Sumislawski; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Arsen Ghasabyan; James Chandler; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-10       Impact factor: 3.313

2.  Body mass index interaction effects with hyperglycemia and hypocholesterolemia modify blunt traumatic brain injury outcomes: a retrospective study.

Authors:  Gregory S Huang; Carl M Dunham; Elisha A Chance; Barbara M Hileman; Daniel J DelloStritto
Journal:  Int J Burns Trauma       Date:  2020-12-15

3.  Assessing Factors Associated with Non-Fatal Injuries from Road Traffic Accidents among Malaysian Adults: A Cross-Sectional Analysis of the PURE Malaysia Study.

Authors:  Zaleha Md Isa; Noor Hassim Ismail; Rosnah Ismail; Azmi Mohd Tamil; Mohd Hasni Ja'afar; Nafiza Mat Nasir; Maizatullifah Miskan; Najihah Zainol Abidin; Nurul Hafiza Ab Razak; Khairul Hazdi Yusof
Journal:  Int J Environ Res Public Health       Date:  2022-07-06       Impact factor: 4.614

4.  Obesity May Not be Protective in Abdominal Stab Wounds.

Authors:  Vivian Hsiao; Jacob Sim; Asha Zimmerman; Andrew Stephen
Journal:  J Emerg Trauma Shock       Date:  2019 Jul-Sep

5.  The relationship between weight indices and injuries and mortalities caused by the motor vehicle accidents: a systematic review and meta-analysis.

Authors:  Enayatollah Homaie Rad; Naema Khodadady-Hasankiadeh; Leila Kouchakinejad-Eramsadati; Fatemeh Javadi; Zahra Haghdoost; Marieh Hosseinpour; Maryam Tavakoli; Ali Davoudi-Kiakalayeh; Zahra Mohtasham-Amiri; Shahrokh Yousefzadeh-Chabok
Journal:  J Inj Violence Res       Date:  2019-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.